TMDX (TransMedics Group) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 25, 2026)


TMDX TransMedics Group Inc TMDX
69 GF Score
Price $77.75
GF Value $166.22
Valuation Possible Value Trap
! 9 Warning Signs
View Full Analysis

What is TransMedics Group Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

TransMedics Group's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

TMDX vs AXGN, ESTA, NVCR: Margin of Safety % (DCF Earnings Based) Comparison

For the Medical Devices subindustry, TransMedics Group's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TransMedics Group Margin of Safety % (DCF Earnings Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, TransMedics Group's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where TransMedics Group's Margin of Safety % (DCF Earnings Based) falls into.


TMDX
69GF Score
TransMedics Group Inc TMDX
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is TransMedics Group (TMDX) Overvalued in 2026?

Based on GuruFocus' analysis, TransMedics Group stock appears to be undervalued. The current stock price of $77.75 is trading 53.2% below its estimated GF Value™ of $166.22. GuruFocus considers TransMedics Group to be Possible Value Trap.

Key valuation signals for TMDX:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: $166.22 vs. price of $77.75 (53.2% below fair value)
  • GF Score™: 69/100 with 9 warning signs

No single metric tells the full story. See the TMDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TransMedics Group Business Description

Address 200 Minuteman Road, Andover, MA, USA, 01810
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
69GF Score

Get the complete analysis for TMDX

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$77.75
Price
$166.22
GF Value